Dr. Eileen Villasante

Dr. Eileen Villasante serves as a key procurement lead at the Naval Medical Research Center, where she oversees the acquisition of advanced biomedical research capabilities and diagnostic technologies critical to force health protection. Her role centers on managing complex research and development contracts that support the development of field-deployable medical systems, infectious disease detection platforms, and analytical instrumentation for austere operational environments. She ensures alignment between scientific objectives and acquisition strategy, facilitating the transition of laboratory innovations into mission-critical tools for Navy and Marine Corps medical personnel. Dr. Villasante maintains a primary working relationship with REES SCIENTIFIC CORPORATION, a trusted partner in the development of specialized laboratory and field diagnostic systems. Her procurement approach emphasizes long-term technical collaboration with vendors possessing deep expertise in analytical instrumentation and biomedical R&D, fostering partnerships that integrate rapid prototyping, validation, and deployment cycles. These relationships are characterized by sustained engagement across multiple contract vehicles, reflecting a preference for vendors with proven capability in high-stakes, mission-driven medical innovation. Her contracting portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition, indicating a focus on technical merit and capability over socioeconomic preferences. While small business participation is not formally prioritized through set-asides, her acquisitions remain open to all qualified offerors, emphasizing performance, innovation, and readiness over socioeconomic categorization. Dr. Villasante’s procurement focus is concentrated in NAICS 541712 (Research and Development in the Physical, Engineering, and Life Sciences) and NAICS 334516 (Analytical Laboratory Instrument Manufacturing). She specializes in acquiring next-generation diagnostic assays, point-of-care testing systems, pathogen detection platforms, and precision analytical instruments tailored for expeditionary medical operations, demonstrating deep domain expertise in military biomedical innovation and laboratory technology procurement.